Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02182180 · ClinicalTrials.gov registry record

SC2i Tissue and Data Repository Protocol

A clinical trial of Critical Illness, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Recruiting
Registry status
5,000
Enrollment target
4
Study locations

NCT02182180: Recruiting study of Critical Illness, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

NCT02182180 is a study of Critical Illness that is actively recruiting participants, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 5,000 participants, above the 3,083-participant average among 91 other Critical Illness trials with a reported enrollment target (62% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02182180, a study of Critical Illness, is actively recruiting participants, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

RECRUITING
Registry status
5,000 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to collect samples of blood, urine, cerebrospinal fluid (CSF, the fluid that surrounds the brain and spinal cord), wound tissue and/or wound fluids, and other body fluids and tissues from people who have been seriously injured or ill. The samples will be used to develop and assess tests and/or tools that doctors can use to decide the best treatment plan for seriously injured or ill military personnel and for civilians. Additonal protocols to use the samples will be submitted as separate protocols.

Primary Outcome

Samples of blood, urine, cerebrospinal fluid, wound tissue and/or wound fluids, and other body fluids and tissues from people who have been seriously injured or ill will be collected. The samples will be used to develop and assess tests and/or tools that doctors can use to decide the best treatment plan for seriously injured or ill military personnel and for civilians. Additional research on the samples will be under separate protocols. This is a collection protocol.

Conditions Studied

Study Locations (4)

Georgia

  • Grady Health Systems - Atlanta
  • Emory University - Atlanta

Maryland

  • Walter Reed National Military Medical Center - Bethesda

North Carolina

  • Duke University Health Systems - Durham

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2014-09-09
Est. Completion 2027-08

What NCT02182180 shows while recruiting

NCT02182180 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,083-participant average among 91 other Critical Illness trials with a reported enrollment target (62% higher).

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 0 interventions.

NCT02182180 reports a single indexed study location in Georgia, Maryland, North Carolina.

Frequently Asked Questions

What is clinical trial NCT02182180 about?

NCT02182180 is a clinical study titled "SC2i Tissue and Data Repository Protocol". The purpose of this study is to collect samples of blood, urine, cerebrospinal fluid (CSF, the fluid that surrounds the brain and spinal cord), wound tissue and/or wound fluids, and other body fluids and tissues from people who have been seriously injured or ill. The samples will be used to develop ...

What is the current status of trial NCT02182180?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2014-09-09. Estimated completion is 2027-08.

What conditions does trial NCT02182180 study?

This clinical trial studies the following conditions: Critical Illness.

Who is sponsoring clinical trial NCT02182180?

This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02182180 being conducted?

This trial has 4 study locations across Georgia, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02182180's enrollment target sits among peer trials

5,000 6th of 91 higher than 86 of 91 other Critical Illness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02182180, the US trial registry maintained by the National Library of Medicine. NCT02182180 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.